RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation
Related Experiment Video
Updated: May 31, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Baisong Liao1, Yan Hu, Gary Brewer
1Department of Molecular Genetics, Microbiology, and Immunology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, USA.
Abstract:
Ionizing radiation (IR) induces proapoptotic gene expression programs that inhibit cell survival. These programs often involve RNA-binding proteins that associate with their mRNA targets to elicit changes in mRNA stability and/or translation. The RNA-binding protein IMP-3 is an oncofetal protein overexpressed in many human malignancies. IMP-3 abundance correlates with tumor aggressiveness and poor prognosis. As such, IMP-3 is proving to be a highly significant biomarker in surgical pathology. Among its many mRNA targets, IMP-3 binds to and promotes translation of insulin-like growth factor II (IGFII) mRNA. Our earlier studies showed that reducing IMP-3 abundance with siRNAs reduced proliferation of human K562 chronic myeloid leukemia cells because of reduced IGF-II biosynthesis. However, the role of IMP-3 in apoptosis is unknown. Here, we have used IR-induced apoptosis of K562 cells as a model to explore a role for IMP-3 in cell survival. Knockdown of IMP-3 with siRNA increased susceptibility of cells to IR-induced apoptosis and led to reduced IGF-II production. Gene reporter assays revealed that IMP-3 acts through the 5' UTR of IGFII mRNA during apoptosis to promote translation. Finally, culture of IR-treated cells with recombinant IGF-II partially reversed the effects of IMP-3 knockdown on IR-induced apoptosis. Together, these results indicate that IMP-3 acts in part through the IGF-II pathway to promote cell survival in response to IR. Thus, IMP-3 might serve as a new drug target to increase sensitivity of CML cells or other cancers to IR therapy.
Insights
The RNA-binding protein IMP-3 promotes cancer cell survival by enhancing insulin-like growth factor II (IGF-II) translation. Reducing IMP-3 increases sensitivity to ionizing radiation (IR)-induced apoptosis, suggesting IMP-3 as a potential therapeutic target.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Ionizing radiation (IR) triggers proapoptotic gene expression, inhibiting cell survival.
- RNA-binding proteins regulate mRNA stability and translation, influencing cellular responses to stress.
- The oncofetal protein IMP-3 is overexpressed in malignancies and linked to tumor aggressiveness.
Purpose of the Study:
- To investigate the role of IMP-3 in ionizing radiation (IR)-induced apoptosis.
- To determine if IMP-3 influences cell survival pathways in response to IR.
- To explore IMP-3 as a potential therapeutic target for enhancing cancer treatment sensitivity.
Main Methods:
- Utilized K562 chronic myeloid leukemia cells as a model for IR-induced apoptosis.
- Employed small interfering RNA (siRNA) to knockdown IMP-3 expression.
- Conducted gene reporter assays to analyze IMP-3's effect on IGF-II mRNA translation.
- Assessed the impact of recombinant insulin-like growth factor II (IGF-II) on IR-induced apoptosis in IMP-3 knockdown cells.
Main Results:
- Knockdown of IMP-3 significantly increased K562 cell susceptibility to IR-induced apoptosis.
- IMP-3 knockdown led to reduced insulin-like growth factor II (IGF-II) production.
- IMP-3 was found to promote IGF-II mRNA translation via its 5' untranslated region (UTR) during apoptosis.
- Recombinant IGF-II partially rescued the apoptotic phenotype observed after IMP-3 knockdown.
Conclusions:
- IMP-3 promotes cancer cell survival in response to ionizing radiation (IR) partly through the insulin-like growth factor II (IGF-II) pathway.
- IMP-3 enhances IGF-II mRNA translation, contributing to cell survival under IR stress.
- Targeting IMP-3 could potentially sensitize chronic myeloid leukemia (CML) cells and other cancers to IR therapy.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Regulation of the Unfolded Protein Response
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways
Regulation of Angiogenesis and Blood Supply
